skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Bromoacetylated analogue of cyanopindolol: an irreversible antagonist at rat beta-adrenoceptors

Journal Article · · Life Sci.; (United States)

A high affinity, chemically reactive cyanopindolol derivative N/sup 8/-bromoacetyl-N/sup 1/-3'-(2-cyano-4-indolyloxy)-2'-hydroxypropyl-(Z)-1,8-diamino-p-menthane (Br-CYP) was synthesized and its interaction with ..beta..-adrenoceptors characterized. Studies with rat heart, lung, brain and red blood cell membranes indicated that the compound displaced /sup 3/H-dihydroalprenolol (/sup 3/H-DHA) from ..beta..-adrenoceptors with IC/sub 50/ values in the nanomolar range. The concentration of functional ..beta..-adrenoceptors in membranes was markedly reduced when membranes were preincubated with Br-CYP and then extensively washed prior to assay. (+/-)Alprenolol and (-)isoproterenol, but not (+)isoproterenol, when included in the preincubation prevented this reduction in binding sites by Br-CYP. Br-CYP was active in vivo when injected intraperitoneally into rats. A dose of 10 ..mu..g/kg reduced the concentration of binding sites in membranes from heart by 30%, lung by 36%, and RBC by 70%, but did not affect sites on brain membranes 16 hours after injection. Higher doses blocked virtually all the /sup 3/H-DHA binding sites in the peripheral organs studied. These results suggest that Br-CYP may be a useful compound for in vivo studies of the biochemistry and pharmacology of ..beta..-adrenergic systems. 27 references, 4 figures, 3 tables.

Research Organization:
National Institute on Aging-GRC, Baltimore, MD
OSTI ID:
6501684
Journal Information:
Life Sci.; (United States), Vol. 41:1
Country of Publication:
United States
Language:
English